Boots and Superdrug – Toxins & Fillers - Why were they not Successful?
In this video, I’ll explore some of the reasons why both Boots and Superdrug have failed to truly tap into the explosive growth in the cosmetic injectable market — and highlight a key lesson smaller c... ...more
Finance in Aesthetics
April 02, 2025•1 min read
After 30+ Years is the Toxin and Filler Market Still GROWING Worldwide?
As far as I’m aware there is no one comprehensive source of statistics that gives a clear picture of the growth rates of the toxin and filler market places, so in this video I’ll explore what we can f... ...more
Finance in Aesthetics
March 19, 2025•1 min read
UK Cosmetic Surgery Groups - Boom to Bust?
I take a look at the financial fortunes and misfortunes of the UK cosmetic surgery industry, which predates the evolution of what we now call the non-surgical medical aesthetics sector by many years. ...more
Finance in Aesthetics
March 12, 2025•1 min read
Is BIGGEST always best? A Review of Non-Surgical Medical Aesthetic Clinic Groups sk:n and therapie
In this post, we dive into the numbers and finances of two of the leading UK based clinic chains, sk:n and Thérapie Clinic, to see if economies of scale help. and whether provision of aesthetic treatm... ...more
Finance in Aesthetics
February 28, 2025•1 min read
Should you Buy CUTERA Shares in 2025?
If you own a system from the device manufacturer Cutera and are convinced about the equipment and its value to your business, should you also consider owning shares in the company that produces the sy... ...more
Finance in Aesthetics
February 24, 2025•1 min read
Should you Buy Shares in HydraFacial in 2025?
If you own a HydraFacial system and are convinced about the equipment and its value to your business, should you also consider owning shares in the company that produces the system? ...more
Finance in Aesthetics
February 18, 2025•0 min read
© GenieAI (Licensed Coaches) 2025 . All rights reserved. Terms and Conditions | Privacy Policy